Max Healthcare Institute Ltd
Max Healthcare Institute Limited is primarily engaged in the providing healthcare services through primary care clinics, multi-speciality hospitals / medical centres and super-speciality hospitals providing operation and management, medical services, clinical, radiology, pathology services and related healthcare services. [1]
- Market Cap ₹ 1,24,226 Cr.
- Current Price ₹ 1,276
- High / Low ₹ 1,297 / 837
- Stock P/E 110
- Book Value ₹ 96.5
- Dividend Yield 0.12 %
- ROCE 14.9 %
- ROE 12.7 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
- Company has delivered good profit growth of 64.0% CAGR over last 5 years
Cons
- Stock is trading at 13.2 times its book value
- Company has a low return on equity of 13.9% over last 3 years.
- Company might be capitalizing the interest cost
- Promoter holding has decreased over last 3 years: -26.9%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE 500 BSE Healthcare BSE 100 BSE 200 Nifty 500
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
1,608 | 1,729 | 1,691 | 1,884 | 2,508 | 3,937 | 4,563 | 5,406 | 7,028 | |
1,467 | 1,616 | 1,535 | 1,595 | 2,101 | 2,986 | 3,322 | 3,914 | 5,180 | |
Operating Profit | 141 | 113 | 156 | 289 | 407 | 951 | 1,241 | 1,492 | 1,849 |
OPM % | 9% | 7% | 9% | 15% | 16% | 24% | 27% | 28% | 26% |
59 | 65 | 56 | 72 | -122 | 110 | 139 | 178 | 82 | |
Interest | 100 | 99 | 101 | 153 | 179 | 101 | 84 | 60 | 165 |
Depreciation | 96 | 94 | 103 | 120 | 174 | 221 | 232 | 245 | 359 |
Profit before tax | 5 | -15 | 8 | 89 | -69 | 739 | 1,064 | 1,365 | 1,406 |
Tax % | -236% | 65% | 102% | -7% | 67% | 18% | -4% | 23% | 24% |
16 | -25 | -0 | 95 | -138 | 605 | 1,104 | 1,058 | 1,076 | |
EPS in Rs | 0.29 | -0.47 | -0.06 | 1.77 | -1.42 | 6.24 | 11.37 | 10.88 | 11.07 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 9% | 14% | 14% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 30% |
3 Years: | 21% |
TTM: | 30% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 64% |
3 Years: | 23% |
TTM: | 7% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 53% |
1 Year: | 36% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 12% |
3 Years: | 14% |
Last Year: | 13% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
Equity Capital | 537 | 537 | 537 | 537 | 966 | 970 | 971 | 972 | 972 |
Reserves | 655 | 627 | 426 | 450 | 4,673 | 5,313 | 6,439 | 7,436 | 8,409 |
874 | 981 | 1,003 | 1,516 | 1,101 | 913 | 689 | 1,299 | 3,010 | |
1,080 | 1,157 | 1,389 | 1,300 | 1,803 | 1,993 | 2,003 | 2,293 | 2,823 | |
Total Liabilities | 3,146 | 3,302 | 3,355 | 3,804 | 8,543 | 9,189 | 10,102 | 12,000 | 15,214 |
2,244 | 2,227 | 2,192 | 2,380 | 6,536 | 7,018 | 7,039 | 8,784 | 11,502 | |
CWIP | 46 | 38 | 87 | 6 | 27 | 151 | 252 | 553 | 900 |
Investments | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 3 |
856 | 1,036 | 1,075 | 1,418 | 1,980 | 2,020 | 2,810 | 2,661 | 2,809 | |
Total Assets | 3,146 | 3,302 | 3,355 | 3,804 | 8,543 | 9,189 | 10,102 | 12,000 | 15,214 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
156 | 166 | 89 | 250 | 118 | 741 | 1,284 | 1,122 | 1,459 | |
-104 | -124 | -17 | -127 | 206 | -764 | -102 | -1,253 | -1,632 | |
-48 | -48 | -74 | 144 | 191 | -294 | -289 | -264 | -164 | |
Net Cash Flow | 4 | -6 | -2 | 267 | 516 | -317 | 893 | -394 | -336 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|
Debtor Days | 53 | 59 | 78 | 80 | 53 | 36 | 27 | 31 | 36 |
Inventory Days | 20 | 24 | 26 | 40 | 34 | 24 | 30 | 26 | 26 |
Days Payable | 184 | 227 | 292 | 273 | 274 | 174 | 215 | 221 | 200 |
Cash Conversion Cycle | -111 | -144 | -188 | -153 | -187 | -114 | -158 | -164 | -138 |
Working Capital Days | 7 | -2 | -136 | -91 | -32 | -13 | -39 | -36 | -34 |
ROCE % | 4% | 6% | 11% | 7% | 12% | 15% | 16% | 15% |
Documents
Announcements
- Closure of Trading Window 26 Jun
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
26 Jun - Newspaper Publication - Information regarding 24th Annual General Meeting, Dividend and Record Date
- Intimation Of Annual General Meeting, Record Date And Communication To Members For Deduction Of Tax At Source On Final Dividend 24 Jun
- Intimation Of Annual General Meeting, Record Date And Communication To Members For Deduction Of Tax At Source On Final Dividend 24 Jun
-
Announcement under Regulation 30 (LODR)-Change in Management
17 Jun - Director - Projects Varadhan Moorthy resigned effective June 17, 2025, due to personal reasons.
Annual reports
Concalls
-
May 2025Transcript PPT REC
-
May 2025TranscriptNotesPPT
-
Feb 2025Transcript PPT REC
-
Jan 2025TranscriptNotesPPT
-
Nov 2024Transcript PPT REC
-
Nov 2024TranscriptNotesPPT
-
Aug 2024Transcript PPT
-
Aug 2024TranscriptNotesPPT
-
May 2024Transcript PPT
-
May 2024TranscriptNotesPPT
-
May 2024TranscriptNotesPPT
-
Feb 2024Transcript PPT
-
Jan 2024TranscriptNotesPPT
-
Nov 2023Transcript PPT
-
Nov 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
-
Aug 2023TranscriptNotesPPT
-
May 2023Transcript PPT
-
Feb 2023Transcript PPT
-
Feb 2023TranscriptNotesPPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
Jun 2022TranscriptPPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
May 2021Transcript PPT
-
Mar 2021TranscriptPPT
-
Feb 2021Transcript PPT
-
Feb 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Feb 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
-
Sep 2020Transcript PPT
-
Aug 2020TranscriptNotesPPT
Leadership
The company is India’s 2nd largest hospital chain in terms of hospital revenue, EBITDA, and market capitalization. [1]